{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:15:59Z","timestamp":1748405759654,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate the effects of simvastatin pretreatment on platelet activation and hypercoagulable state in septic mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>60 Sprague\u2013Dawley (SD) mice were divided into three groups: healthy control (group A), sepsis (group B) and simvastatin intervention (group C). The sepsis model was established by intraperitoneal injection of lipopolysaccharide in the group B: the group A was injected with normal saline, and the group C was injected with 10\u00a0\u03bcg\/ml simvastatin 5\u00a0ml of simvastatin for 3\u00a0h. The changes of protein expression were detected by Western blot, blood coagulation indexes were analyzed, and the levels of serum platelet activating factor, thrombomodulin, interleukin 6 (IL-6), tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1 \u03b2 (IL-1\u03b2), superoxide dismutase (SOD) and malondialdehyde (MDA) were detected by enzyme linked immunosorbent assay (ELISA) detection kit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>The levels of thrombomodulin and platelet activating factor in mice of the group B were significantly higher than those in the group A (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The levels of thrombomodulin and platelet activating factor in the group C of mice were significantly lower than those in the group B (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), which were down-regulated by 20.44% and 33.33%, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The PT and APTT times of mice in the group B were significantly lower than those in the group A (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The PT and APTT times of mice in the group C were significantly higher than those in the group B (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), which were upregulated by 29.01% and 13.08%, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The SOD level of mice in the group B was significantly lower than that in the group A, and the MDA level was significantly higher than that in the group A (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The SOD level in the group C of mice was significantly higher than that in the group B, which was upregulated by 24.77%, and the MDA level was significantly lower than that in the group B, which was down-regulated by 22.96% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The levels of serum IL-6, TNF-\u03b1 and IL-1\u03b2 in mice of the group B were higher than those in the group A (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The levels of serum IL-6, TNF-\u03b1 and IL-1\u03b2 in the group C of mice were lower than those in the group B by 45.97%, 28.72% and 16.59%, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The expression levels of AMPK and UCP2 proteins in the group B of mice were lower than those in the group A (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The expression levels of AMPK and UCP2 proteins in the group C of mice were higher than those in the group B, which were upregulated by 55.00% and 28.81%, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Simvastatin pretreatment can improve platelet activation and hypercoagulable state in septic mice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02677-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:41:05Z","timestamp":1748360465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of simvastatin pretreatment on platelet activation and hypercoagulable state in septic mice"],"prefix":"10.1186","volume":"30","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"2020","key":"2677_CR1","doi-asserted-by":"publisher","first-page":"1839762","DOI":"10.1155\/2020\/1839762","volume":"14","author":"FM de Jesus Oliveira","year":"2020","unstructured":"de Jesus Oliveira FM, Gon\u00e7alves-de-Albuquerque CF, de Moraes IMM, et al. Simvastatin posttreatment controls inflammation and improves bacterial clearance in experimental sepsis. Mediators Inflamm. 2020;14(2020):1839762. https:\/\/doi.org\/10.1155\/2020\/1839762.","journal-title":"Mediators Inflamm"},{"issue":"19","key":"2677_CR2","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.3390\/ijms21197236","volume":"21","author":"L Ne\u017ei\u0107","year":"2020","unstructured":"Ne\u017ei\u0107 L, \u0160krbi\u0107 R, Amid\u017ei\u0107 L, et al. Protective effects of simvastatin on endotoxin-induced acute kidney injury through activation of tubular epithelial cells\u2019 survival and hindering cytochrome C-mediated apoptosis. Int J Mol Sci. 2020;21(19):7236. https:\/\/doi.org\/10.3390\/ijms21197236.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2677_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13054-023-04387-9","volume":"27","author":"SM Pienkos","year":"2023","unstructured":"Pienkos SM, Moore AR, Guan J, et al. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials. Crit Care. 2023;27(1):126. https:\/\/doi.org\/10.1186\/s13054-023-04387-9.","journal-title":"Crit Care"},{"issue":"12","key":"2677_CR4","doi-asserted-by":"publisher","first-page":"8314","DOI":"10.1111\/jcmm.14709","volume":"23","author":"X Zheng","year":"2019","unstructured":"Zheng X, Zhang W, Wang Z. Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFR\u03b2\/PI3K\/Akt\/IQGAP1 signalling pathway. J Cell Mol Med. 2019;23(12):8314\u201327. https:\/\/doi.org\/10.1111\/jcmm.14709.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2677_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-022-04025-w","volume":"26","author":"AJ Boyle","year":"2022","unstructured":"Boyle AJ, Ferris P, Bradbury I, et al. Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial. Crit Care. 2022;26(1):164. https:\/\/doi.org\/10.1186\/s13054-022-04025-w.","journal-title":"Crit Care"},{"issue":"7","key":"2677_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/cells11071148","volume":"11","author":"V La Mura","year":"2022","unstructured":"La Mura V, Gagliano N, Arnaboldi F, et al. Simvastatin prevents liver microthrombosis and sepsis-induced coagulopathy in a rat model of endotoxemia[J]. Cells. 2022;11(7):1148. https:\/\/doi.org\/10.3390\/cells11071148.","journal-title":"Cells"},{"issue":"1","key":"2677_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-022-04025-w","volume":"26","author":"AJ Boyle","year":"2022","unstructured":"Boyle AJ, Ferris P, Bradbury I, et al. Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 trial[J]. Crit Care. 2022;26(1):164. https:\/\/doi.org\/10.1186\/s13054-022-04025-w.","journal-title":"Crit Care"},{"issue":"6","key":"2677_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.21037\/atm.2020.02.101","volume":"8","author":"TK Oh","year":"2020","unstructured":"Oh TK, Song IA, Choi S. Prior statin therapy and mortality among critically ill patients: a systemic review and meta-analysis of cohort studies. Ann Transl Med. 2020;8(6):396. https:\/\/doi.org\/10.21037\/atm.2020.02.101.","journal-title":"Ann Transl Med"},{"issue":"6","key":"2677_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.21037\/atm.2020.02.101","volume":"8","author":"TK Oh","year":"2020","unstructured":"Oh TK, Song IA, Choi S. Prior statin therapy and mortality among critically ill patients: a meta-analysis of cohort studies[J]. Ann Transl Med. 2020;8(6):396. https:\/\/doi.org\/10.21037\/atm.2020.02.101.","journal-title":"Ann Transl Med"},{"issue":"11","key":"2677_CR10","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s11010-022-04463-8","volume":"477","author":"CHR Catal\u00e3o","year":"2022","unstructured":"Catal\u00e3o CHR, de Oliveira SA, Santos-Junior NN, et al. Pre-treatment and continuous administration of simvastatin during sepsis improve metabolic parameters and prevent CNS injuries in survivor rats. Mol Cell Biochem. 2022;477(11):2657\u201367. https:\/\/doi.org\/10.1007\/s11010-022-04463-8.","journal-title":"Mol Cell Biochem"},{"issue":"254","key":"2677_CR11","doi-asserted-by":"publisher","first-page":"117701","DOI":"10.1016\/j.lfs.2020.117701","volume":"1","author":"MK Oliveira","year":"2020","unstructured":"Oliveira MK, Dos Santos RS, Cabral LDM, Vilela FC, Giusti-Paiva A. Simvastatin attenuated sickness behavior and fever in a murine model of endotoxemia. Life Sci. 2020;1(254):117701. https:\/\/doi.org\/10.1016\/j.lfs.2020.117701.","journal-title":"Life Sci"},{"issue":"7","key":"2677_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/cells11071148","volume":"11","author":"V La Mura","year":"2022","unstructured":"La Mura V, Gagliano N, Arnaboldi F, et al. Simvastatin prevents liver microthrombosis and sepsis induced coagulopathy in a rat model of endotoxemia. Cells. 2022;11(7):1148. https:\/\/doi.org\/10.3390\/cells11071148.","journal-title":"Cells"},{"issue":"1","key":"2677_CR13","doi-asserted-by":"publisher","first-page":"14652","DOI":"10.1038\/s41598-018-32376-4","volume":"8","author":"L Ne\u017ei\u0107","year":"2018","unstructured":"Ne\u017ei\u0107 L, \u0160krbi\u0107 R, Amid\u017ei\u0107 L, et al. Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin\/NF-\u03baB\/p65 expression. Sci Rep. 2018;8(1):14652. https:\/\/doi.org\/10.1038\/s41598-018-32376-4.","journal-title":"Sci Rep"},{"key":"2677_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jss.2018.07.016","volume":"232","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang X, Yang W, et al. Effect of simvastatin on the intestinal Rho\/ROCK signaling pathway in rats with sepsis. J Surg Res. 2018;232:531\u20138. https:\/\/doi.org\/10.1016\/j.jss.2018.07.016.","journal-title":"J Surg Res"},{"issue":"4","key":"2677_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s12640-020-00222-z","volume":"38","author":"CHR Catal\u00e3o","year":"2020","unstructured":"Catal\u00e3o CHR, Santos-Junior NN, da Costa LHA, et al. Simvastatin prevents long-term cognitive deficits in sepsis survivor rats by reducing neuroinflammation and neurodegeneration. Neurotox Res. 2020;38(4):871\u201386. https:\/\/doi.org\/10.1007\/s12640-020-00222-z.","journal-title":"Neurotox Res"},{"issue":"1","key":"2677_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/mmr.2021.12541","volume":"25","author":"L Xu","year":"2022","unstructured":"Xu L, Wu XM, Zhang YK, et al. Simvastatin inhibits the inflammation and oxidative stress of human neutrophils in sepsis via autophagy induction. Mol Med Rep. 2022;25(1):25. https:\/\/doi.org\/10.3892\/mmr.2021.12541.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2677_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11596-022-2526-3","volume":"42","author":"M Xu","year":"2022","unstructured":"Xu M, Luo LL, Du MY, et al. Simvastatin improves outcomes of endotoxin-induced coagulopathy by regulating intestinal microenvironment. Curr Med Sci. 2022;42(1):26\u201338. https:\/\/doi.org\/10.1007\/s11596-022-2526-3.","journal-title":"Curr Med Sci"},{"issue":"5","key":"2677_CR18","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/ijms23052596","volume":"23","author":"L Ne\u017ei\u0107","year":"2022","unstructured":"Ne\u017ei\u0107 L, Amid\u017ei\u0107 L, \u0160krbi\u0107 R, et al. Amelioration of endotoxin-induced acute lung injury and alveolar epithelial cells apoptosis by simvastatin is associated with up-regulation of survivin\/NF-kB\/p65 pathway. Int J Mol Sci. 2022;23(5):2596. https:\/\/doi.org\/10.3390\/ijms23052596.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2677_CR19","doi-asserted-by":"publisher","first-page":"152411","DOI":"10.1016\/j.imbio.2023.152411","volume":"228","author":"J Hussain","year":"2023","unstructured":"Hussain J, Ousley CG, Krauklis SA, et al. Prophylactic simvastatin increased survival during endotoxemia and inhibited granulocyte trafficking in a cell-intrinsic manner. Immunobiology. 2023;228(4):152411. https:\/\/doi.org\/10.1016\/j.imbio.2023.152411.","journal-title":"Immunobiology"},{"key":"2677_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02835-5","author":"G Ates","year":"2023","unstructured":"Ates G, Tamer S, Ozkok E, et al. Determination of trace elements and electrolyte levels in kidney tissue of simvastatin-treated septic rats. Naunyn Schmiedebergs Arch Pharmacol. 2023. https:\/\/doi.org\/10.1007\/s00210-023-02835-5.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"2677_CR21","doi-asserted-by":"publisher","first-page":"e0293630","DOI":"10.1371\/journal.pone.0293630","volume":"18","author":"H Azizian","year":"2023","unstructured":"Azizian H, Farhadi Z, Bader M, et al. GPER activation attenuates cardiac dysfunction by upregulating the SIRT1\/3-AMPK-UCP2 pathway in postmenopausal diabetic rats. PLoS ONE. 2023;18(12):e0293630. https:\/\/doi.org\/10.1371\/journal.pone.0293630.","journal-title":"PLoS ONE"},{"issue":"13","key":"2677_CR22","doi-asserted-by":"publisher","first-page":"1038802","DOI":"10.3389\/fphar.2022.1038802","volume":"9","author":"P Zhao","year":"2023","unstructured":"Zhao P, Li X, Yang Q, et al. Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-\u03b1\/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice. Front Pharmacol. 2023;9(13):1038802. https:\/\/doi.org\/10.3389\/fphar.2022.1038802.","journal-title":"Front Pharmacol"},{"key":"2677_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161321","volume":"34","author":"DG Hardie","year":"2014","unstructured":"Hardie DG. AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels[J]. Annu Rev Nutr. 2014;34:31\u201355. https:\/\/doi.org\/10.1146\/annurev-nutr-071812-161321.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"2677_CR24","doi-asserted-by":"publisher","first-page":"166028","DOI":"10.1016\/j.bbadis.2020.166028","volume":"1867","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhou Y, Cao J, et al. Uncoupling protein 2 protects against sepsis-induced acute lung injury via regulating NLRP3 inflammasome-mediated pyroptosis[J]. Biochim Biophys Acta Mol Basis Dis. 2021;1867(3):166028. https:\/\/doi.org\/10.1016\/j.bbadis.2020.166028.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"2677_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.21037\/atm-20-4819","volume":"9","author":"JY Mao","year":"2021","unstructured":"Mao JY, Su LX, Li DK, et al. The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism. Ann Transl Med. 2021;9(3):259. https:\/\/doi.org\/10.21037\/atm-20-4819.","journal-title":"Ann Transl Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02677-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:41:05Z","timestamp":1748360465000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02677-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2677"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02677-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}